Vol. 105, No. 3, 1982 April 14, 1982
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS Pages 1066-1071
ACID SEQUENCE OF GALACTOSAMINE-CONTAINING GLYCOPEPTIDES REGION OF A HUMAN IMMUNOGLOBULIN D
AMINO
Tatsunori
Takayasu, Satoru Tomotaka Shinoda,
Suzuki, Tsuneo
Fuyuki Kametani, Nobuhiro Takahashi, Okuyama and Eisuke Munekata
Department of Chemistry, Tokyo Metropolitan University, 158 and Institute of Applied Biochemistry, University Ibarakiken, 305, Japan Received
February
IN THE HINGE
Setagaya-ku, of Tsukuba,
Tokyo
15, 1982
Amino acid sequence and the location of seven galactosamine oligosaccharide moieties of the hinge region of the 6 chain of human IgD NIG-65 have been determined. These oligosaccharide moieties are distributed in two distinct fashions: 1) three clusters each consisting of five amino acid residues with two consecutive attachment sites either Ala-X-Ala-Ser-Ser or Ala-X-Ala-Thr-Thr, where X can be any amino acid including proline, 2) one triplet sequence Val-Pro-Thr with one attachment site. We propose two rules with regard to the acceptor sequence for galactosamine oligosaccharides, the quintet sequence rule and triplet sequence rule. Of two different chain
types
of human IgD,
virtually
N-acetylglucosamine
in the Fc region(l)
established location
has recently
in part
to our result the number
kinds,
heavy chains views roles
the
as well
N-acetylgalactosamine
of five
class,
on the relationship
its
WAH(5),
NIG-65.
which
Since
of oligosaccharide are
of the
are now avaiable
apparently
immunoglobulin
is contrasting
needed classes
for
additional
data
to have general and their
biological
and functions. This
communication
describes
galactosamine-containing
the
glycopeptides,
isolation and amino and the tentative
galactosamine
oligosaccharide
moieties
In connection
to our
a new hypothesis
galactosamine-oligosaccharide
results,
will
MATERIALS
in the hinge
be also
region
acid sequences of location of seven of a human IgD.
on the acceptor
sequences
AND METHODS
0006-291X/82/071066-06$01.00/0 0 1982 by Academic Press, Inc. in an-v form reserved.
of reproduction
of
described.
Human IgD NIG-65 was isolated from the plasma of a patient with myeloma by ammonium sulfate fractionation, DEAE-Sephadex A-50 column chromatography, and Bio gel A-5m gel filtration. Although it existed
Copynghi .A// righa
heavy
tentative
much data
human immunoglobulins,
chain,
between
protein
protein
principal
6
6
As to the other
oligosaccharide,
for
for
and the location
of four
remaining
been reported
in the
as by other(4).
type
obtained
identified
oligosaccharide has been found type numbers and the location have been
and their
by the authors(2,3)
carbohydrate,
for
of oligosaccharide
1066
multiple in
BIOCHEMICAL
Vol. 105, No. 3, 1982
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
it was shown to be essentially homomultiple bands on isoelectrofocusing, SDS-polyacrylamide gel electrophoresis, and geneous by immunoelectrophoresis, The isolation, purification and characterization N- and C-terminal analyses. procedures have been described by Shinoda, et al(2). Fd(t) fragment was prepared from the Fab(t) fragment after the complete reduction and aminoethylation according to the procedure previously described(6,7) and was shown to be homogenous in SDS-polyacrylamide gel electrophoresis and N-terminal analysis. Purified aminoethyl(AE-)Fd(t) fragment(l20 mg in O.lM NH HC03) was t! ,3) and the digested with 2.6 mg of TPCK-trypsin in the way as described( digest was chromatographed on a column of DEAE-Sephadex A-25(1.5 x 42 cm). The column was eluted at room temperature first with 360 ml of 0.Ol.M NH4HC0310% 1-propanol and then by a linear gradient of an increasing NH HC03 concentration(O.Ol-0.6M) containing 10% 1-propanol. Flow rate was 1 %.4 ml/h, and fractions of 4.4 ml were collected. Peptides were further purified by gel filtration with Bio gel F-6 colum(l.5 x 98 cm) in O.lM NH4HC0 at room temperature. Another portion of the AE-Fd(t) fragment(100 mg in ;I2 ml O.lM NH4HC03) was also digested with 3.4 mg of V8 protease at 37°C for 20 h and the The V8 peptides were isolated and purified in the digest was lyophilyzed. same manners as described above. HF treatment of the GalN-containing peptides was carried out in the similar way as reported(8) and the deglycosilated peptides were purified either by gel filtration with Sephadex G-25 or ion-exchange column chromatography with DEAE-Sephasose CL-6B according to the methods described(2). Amino acid sequence analyses and identification of PTH-amino acids by High Performance Liquid Chromatography were carried out as essentially described(6,7).
RESULTS AND DISCUSSION Following trypsin
the chromatography
digest
an elution (GalN
of the completely
pattern
shown
T) was eluted
further
purified
composition residues, component
which
cause
in table
of steric
and aminoethylated
indicated
had six
cleavage hinderance
with
did
the
at lysyl-alanine
of the fragment,
in the
peptide
figure.
not contain
sequence
It
amino
was
acid
any glucosamine
Upon sequence analysis about 10% of an additional
to contain
by massive
Fd(t)
of P-6 and its
1. The peptide
more residues
A-25
A GalN-containing
as Frl
on a column
observation(2,3).
was shown
of DEAE-Sephadex
was obtained.
filtration
the previous the peptide
at incomplete
reduced
in Fig.l(A)
at the position by gel
was given
, confirming
Lys-
on a column
up to 11th minor
Trp-Pro-Glu-Ser-Pro-
bond with
trypsin,
GalN oligosaccharide
probably
moieties
be-
adjacent
to it. To facilitate
sequence
determination
HF to remove GalN oligosaccharide chromatography HF). shown
The peptide
of the peptide
in Table
ses of the were Fd(t)
fragment
from
was first
and was purified , giving
acid
residues
by manual
of the sequence GalN-containing
of the completely
the procedures
similar 1067
exchange
peptide,
GalN-T(
and its
GalN content The first
Edman degradation GalN-Sl reduced
to those
with
amount.
was determined peptides
treated
by ion
a single
10% of the original
was determined
the V8 digest
through
moieties filtration
of 32 amino to about
2. The rest
two different
isolated
by gel
consisted
to have decreased
sequence rized
followed
the peptide
was 23
as summa-
by sequence
analy-
and GalN-S2,
which
and aminoethylated
applied
to the tryptic
Vol. 105, No. 3, 1982
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
3.
d 0
50
15~1
100
A
Fr.1 fraction
200 number(L.4
ml)
NH4 HC03
0
B
Fig.
1.
peptides.
F-r. 1
An elution
S2 were
respectively P-6,
whose
GalN-Sl by manual and 11th
steps
were
for
consisted
because tially
in Fig.l(B).
in pure were
200 number(7.8
ml)
HF-treated
1) composition
I except for the sequence
directly
throughout 8th,
12th with tryptic
but
were
data
peptide
GalN-T(BF),
obtained
the results The se-
The PTH-derivaidentified,
for
but were
the sequence
moiety,
HF-treated(par-
and 2) all
the composition
8th
V8 glycopeptide
residues.
directly
throughout
to N-acetylgalactosamine
the sequence
4 threonine residues found in as shown in table 2. Altogether
with
the 7th,
from
The other
not
each linking
1068
deduced
Edman degradation.
were
and GalN-
filtration
from
5 threonine
by manual
with
1.
was determined
peptide,GalN-T(HF). including
GalN-Sl
the gel
in Table
The PTH-derivatives
and 13th
residue
following
determined
tryptic
chromatography
and Fr2,
The sequence
2).
of 18 residues
to be threonine deglycosylated)
forms
column
Frl
summerized
of 17 residues. not
the 7th,
From peaks
obtained
was determined from
ion exchange
compositions
consisted
,GalN-S2
deduced
of the
Edman degradation(Table
obtained
tives
profile
was shown
Bio
gel
I50 fraction
Separation of trypsin(A) and S.aureus V8 protease peptides from aminoethyl-Fd(t) fragment. Separations were carried out with DEAE-Sephadex A-25 column(l.5 x 42 cm) at room temperature. Details are described in the text.
V8 peptides
quence
tboFr.2
the amino
were of the
recovered 35-residue
acids in
Vol. 105, No. 3, 1982
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
Table 1
AMINO ACID COMPOSITIONOF ~INEWAINIK IN THE HIKE REGIONOF A HUMANIgD NIG65. GalN and GlcN were determined after hydrolysis with 6N x1 for 24 h at 11O'C. Values of less than 0.2 were anitted except GalN and GlcN.
-IIDES
GalN-T
GalN-T (HF)
GalN-Sl
GalN-S2
1.0
0.8
0.9
0.9
1.8
1.0 5.7 4.0 5.2 4.3 2.0 8.9 0.9
2.0 1.0 6.2 3.3 3.9 3.3 2.0 8.5 1.1
1.2
1.2
2.6 0.0
0.2 0.0
LYS
His Ar& Asp Thr Ser Glu PI-0 GlY Ala Val Met Ile Leu
2.0 0.9 5.0 0.9
1.1 2.6 4.4 3.2
1.3 1.8 3.8
3.6 0.9
1.0
TY~ Phe GalN GlcN
peptide
which
covered
determined(Table
2).
The tentative difference
location
or serine
and by the
at a given assignment
,24th,
25th,
quences
GalN-oligosaccharide
step
of peptides
failure
and 30th
the
containing
each has two consective
region
sequence
was
was assigned
and after
determination.
by
the HF treatment
the PTH-derivative
to each of the
threonine
shown inTable2,
before
to detect
during
of one GalN
29th
The sequence
1.7 0.0
of seven GalN-oligosaccharides
in the GalN content
of the peptides allowed
the entire
0.5 0.0
of threonine This
operation
7th and 8th serine,
one to 11th
residues.
these are GalN-binding
three characteristic sites either Ser-Ser
quintet seor Thr-Thr,
but neither Ser-Thr nor Thr-Ser sequence: they are 4-Ala-Gln-Ala-Ser-Ser8, 21-Ala-Lys-Ala-Thr-Thr-25 and 26-Ala-Pro-Ala-Thr-Thr-30, respectively. basic
sequence
any amino acid "quintet rule"
can be drawn including
as the acceptor
hinge
region
other
GalN-oligosaccharide-containing
oligosaccharide
as Ala-X-Ala-Ser-Ser(or
proline.
of human identified
6 chain
The finding sequence
for
and that
it
Thr-Thr), allowed
6 hinge 1069
X can be
us to propose
a
the GalN-oligosaccharide may also
glycoproteins. in the
where
exist
in the
be applicable
for
Six of seven in this
form.
The
GalN-
The
the
Vol. 105, No. 3, 1982
BIOCHEMICAL
Table 2.
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
M.IINO ACID SIQJFNCC OF ~SAMINF-CONTAINIMS GLYCOPIlPTIDES IN TKE IIINGE REGION OF A HUMAN IgD r:IG-65 12
GalN-T
(major)
3
4
5
6
7
8
9
11
Ala-Gin-Ala(Serfier)Val-Pro(Thr)Ala-Gln-ProCHO CHO CHO
i (minor)(Trp-Pro-G111-Ser-Pro(Lys)Ala-Gln-Ala(S~r~~r))
trio ccl0
Ala-Gln-Ala-Ser-Ser-Val-Pro-Thr-Ala-Gln~~~~~~~~777 Pro-Gln-Ala-Clu-Gly(Ser)Leu-Ala(Lys)Ala---J 7 --I / 7 --7 --7 -7 --7 -7 Thr-Thr-Ala77-7 ~ __ __ Ser-Pro-Lys-Ala-Gin-Ala(SerEer)Val-Pro( I ---T ---? ---T ---? 1 CHO CHO 1 ---J --7 --7 Thr)Ala-Gin-Pro-Gln-Ala-Glu CHO---7-777‘-7 Gly-Ser-Leu-Ala-Lya -Ala(TQrmQr)Ala-PrO-1 -1 1-1 CKO CHO -7 --7 --7 Ala(Thr)@hr)ArS-Asn-Thr-Gly-ArS 7 CA0 CA0 1 1 1 -7 1 --7 --7
GalN-T(HF)
-
10
-
GalN-Sl
Gall<-S2
TOTAL SEQUENCE qlo NH*-Ser-Pro-Lys-ALA-Gin-ALA-SER PI Pro-Gin-Ala-Glu-Gly-Scr-Lclj-ALA-L,
cyo cyo -SER-Val-PRO-THR-Ala-Glncijo ci'o ~,s-ALA-T~IR-TI11~-AI,A-proII
t
cyo cyo ALA-THR-THH-Arg-Asn-Thr-Gly-Arp,-COOH 4
remaining
is
sequence
linked
contrasting
oligosaccharide the doublet appeared
to the threonine
to the case of the
sequence
in the different
We would
ancies
with
rides between an individual
reported
of Pro-Ser
have a galactosamine rule.
are
moieties
o(1 hinge
in the hinge
protein, that
in the 9-Val-Pro-Thr-11
to be linked
in which
region(g).
the attachment
and location
in
sequence
reported
is possible appear some
of galactosamine
but our present result and ether(5), sample variation rather than technical 1070
residue to for
the
of the galactosamine-oligo-
the threonine residue in the triplet residue has a cis-configuration. There to the number
the GalN-
more generality
to
regard
all
The triplet is also
suggesting
triplet
to the serine
dl-microglobulin,
oligosaccharide(lO),
suggest
saccharide moiety when the proline
residue
this
only discrep-
oligosaccha-
may be attributed
problems.
to
Vol. 105, No. 3, 1982 The presence human
6
chain
GalN,
which
the GalN-rich
is
rather segment
proteolytic
caused
by massive
possible
of seven
AND BIOPHYSICAL
GalN-oligosaccharides
is characteristic
various
the restricted
BIOCHEMICAL
uncommon of the enzymes.
of
the high
in immunoglobulins.
This
might
of
the hinge
region
local
concentration
of the of
As in the case of the dl to be very
be due to the steric moieties
Such characteristic significance
in
& h' in g e was shown
GalN-oligosaccharide
region.
biological
because
RESEARCH COMMUNICATIONS
which
may have
resistant
to
hinderance
are distributed some correlations
along to
IgD.
ACKNOWLEDGEMENTS Department of Medicine, Osaka University We thank Dr. Akira Shimizu, School of Medicine for providing myeloma plasma NIG-65, and Dr. A. Yamada for general discussion. This work was supported in part by a grant-in-aid from the Ministryof Education, Science and Culture of Japan, and by research funds from the Ito Science Foundation.
REFFERENCES 1.
2. 3. 4. 5. 6. 7. 8. 9. 10.
Prah1,J.W. and Grey,H.M. (1970) Biochemistry 9, Spiegelberg,H.L., 2115-2122 Shinoda,T., Takahashi,N., Takayasu,T., Okuyama,T. and Shimizu,A. (1981) Proc. Natl. Acad. Sci. USA 78, 785-789 Takayasu,T., Takahashi,N. and Shinoda,T. (1980) Biochem. Biophys. Res. Commun. 97, 635-641 Lin,L.-C. and Putnam,F.W. (1981) Proc. Natl. Acad. Sci. USA 78, 504-508 Putnam,F.W., Takahashi,N., Tetaert,D., Debuire,B. and Lin,L.-C. (1981) Acad. Sci. USA 78, 6168-6172 Proc. Natl. Takahashi,N., Takayasu,T., Isobe,T., Shinoda,T., Okuyama,T. and Shimizu, A. (1979) J. Biochem. 86, 1523-1535 Takayasu,T., Takahashi,N., Shinoda,T., Okuyama,T. and Tomioka,H. (1981) J. Biochem. 89, 421-436 Mort,A.J. and Lamport,D.T.A. (1977) Anal. Biochem. 82, 289-309 Liu,Y.-S.V., Low,T.L.K., Infante,A. and Putnam,F.W. (1976) Science 193 I 1017-1020 Takagi,T., Takagi,K. and Kawai,T. (1981) Biochem. Biophys. Res. Commun. in press
1071